ESOPMay 28, 2026, 04:03 PM
Opus Genetics Grants 698,000 Stock Options to New Employees
AI Summary
Opus Genetics, Inc. announced that its Compensation Committee approved equity awards for ten new non-executive employees. These awards, granted under the Company's 2021 Inducement Plan and in accordance with Nasdaq Listing Rule 5635(c)(4), consist of options to purchase an aggregate of 698,000 shares of common stock. The options have an exercise price equal to the fair market value on the grant date and vest over a four-year period.
Key Highlights
- Opus Genetics granted equity awards to ten new non-executive employees.
- Awards were options to purchase an aggregate of 698,000 shares of common stock.
- Approved under the Company's 2021 Inducement Plan, as amended.
- Approved in accordance with Nasdaq Listing Rule 5635(c)(4).
- Option exercise price equals fair market value on the grant date.
- Options vest over four years: 25% on one-year anniversary, then quarterly.
Price Impact
More from IRD